We are live on ! Find out more
ABCL icon

AbCellera Biologics

86 hedge funds and large institutions have $2.42B invested in AbCellera Biologics in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 19

65% more call options, than puts

Call options by funds: $2.35M | Put options by funds: $1.42M

43% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 14

39% more funds holding

Funds holding: 6286 (+24)

1.16% more ownership

Funds ownership: 25.65%26.81% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

12% less capital invested

Capital invested by funds: $2.74B → $2.42B (-$324M)

Holders
86
Holders Change
+24
Holders Change %
+38.71%
% of All Funds
1.51%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
43
Increased
20
Reduced
14
Closed
19
Calls
$2.35M
Puts
$1.42M
Net Calls
+$932K
Net Calls Change
+$932K
Name Holding Trade Value Shares
Change
Change in
Stake
CC
101
Covalis Capital
United Kingdom
-$201K -5,000 Closed
CAAS
102
Capital Asset Advisory Services
Michigan
-$4K -93 Closed
VFA
103
Valeo Financial Advisors
Indiana
-$2K -39 Closed
Bank of America
104
Bank of America
North Carolina
+$40 +1 New
HI
105
Harbour Investments
Wisconsin
+$199 +5 New